000 01266nam a2200337 a 4500
005 20250918190107.0
008 130222 2012 nyua 001 0 eng
020 _a9781936113217
_cRM403.75
039 9 _a201303200906
_bazriq
_c201303151213
_dazriq
_c201303131530
_dIzzati
_y02-22-2013
_zIzzati
040 _dUKM
090 _aWK810.T991 2012 9HUKM
090 _aWK810
_b.T991 2012 9HUKM
245 0 0 _aType 1 diabetes /
_cedited by Jeffrey A. Bluestone, Mark A. Atkinson, Peter Arvan.
260 _aCold Spring Harbor, N. Y. :
_bCold Spring Harbor Laboratory Press,
_c2012.
300 _axi, 305 p. :
_bill. ;
_c26 cm.
490 1 _aCold spring harbor perspectives in medicine
650 2 _aDiabetes Mellitus, Type 1
_xetiology.
650 2 _aDiabetes Mellitus, Type 1
_xdrug therapy.
650 2 _aAngiogenesis Inducing Agents.
700 1 _aBluestone, Jeffrey A.
700 1 _aAtkinson, Mark A.
700 1 _aArvan, Peter.
830 0 _aCold spring harbor perspectives in medicine.
907 _a.b15578999
_b2019-11-12
_c2019-11-12
942 _c01
_n0
_kWK810.T991 2012 9HUKM
914 _avtls003523867
990 _aizzati/azriq
991 _aJabatan Perubatan, PPUKM
998 _ah
_b2013-09-02
_cm
_da
_feng
_gnyu
_y0
_z.b15578999
999 _c540800
_d540800